The firm demonstrates extreme risk aversion through a clean capital structure, evidenced by a negligible 0.05% debt-to-equity ratio that minimizes financial leverage.
| Metric | Oct'24 | Oct'23 | Oct'22 | Oct'21 |
|---|
| Total Current Assets | 2.84M | 2.18M | 2.26M | 473.59K |
| Cash & Short-Term Investments | 547.5K | 1.03M | 574.71K | 72.69K |
| Cash Only | 547.5K | 1.03M | 574.71K | 72.69K |
| Short-Term Investments | 0 | 0 | 0 | 0 |
| Accounts Receivable | 1.11M | 710.78K | 1.53M | 79.71K |
| Days Sales Outstanding | 170.05 | 105.5 | 290.13 | 31.25 |
| Inventory | 71.49K | 95.87K | 94.17K | 316.51K |
| Days Inventory Outstanding | 133.58 | 112.52 | 67.51 | 371.28 |
| Other Current Assets | 1.09M | 233.48K | 59.52K | 0 |
| Total Non-Current Assets | 239.04K | 88.72K | 254.09K | 120.62K |
| Property, Plant & Equipment | 174.7K | 70.44K | 62.82K | 106.76K |
| Fixed Asset Turnover | 13.63x | 34.91x | 30.55x | 8.72x |
| Goodwill | 0 | 0 | 0 | 0 |
| Intangible Assets | 7.62K | 8.4K | 9.35K | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 407 | 9.88K | 181.92K | 13.86K |
| Total Assets | 3.08M | 2.26M | 2.52M | 594.22K |
| Asset Turnover | 0.77x | 1.09x | 0.76x | 1.57x |
| Asset Growth % | 36.14% | -10.08% | 323.87% | - |
| Total Current Liabilities | 1.52M | 1.24M | 2.37M | 1.16M |
| Accounts Payable | 24.07K | 197.16K | 129.72K | 89.34K |
| Days Payables Outstanding | 44.97 | 231.4 | 92.99 | 104.8 |
| Short-Term Debt | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 325.92K | 250.55K | 1.21M | 164.81K |
| Other Current Liabilities | 0 | 0 | 0 | 0 |
| Current Ratio | 1.87x | 1.75x | 0.96x | 0.41x |
| Quick Ratio | 1.82x | 1.67x | 0.92x | 0.14x |
| Cash Conversion Cycle | 258.65 | -13.38 | 264.64 | 297.72 |
| Total Non-Current Liabilities | 52.74K | 9.49K | 0 | 15.86K |
| Long-Term Debt | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 52.74K | 9.49K | 0 | 15.86K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Total Liabilities | 1.58M | 1.25M | 2.37M | 1.17M |
| Total Debt | 70.32K | 31.46K | 26.19K | 35.2K |
| Net Debt | -477.18K | -1M | -548.52K | -37.48K |
| Debt / Equity | 0.05x | 0.03x | 0.17x | - |
| Debt / EBITDA | 0.09x | 0.03x | 0.12x | - |
| Net Debt / EBITDA | -0.58x | -0.83x | -2.41x | - |
| Interest Coverage | - | - | 1015.59x | -419.58x |
| Total Equity | 1.51M | 1.01M | 150.28K | -578.18K |
| Equity Growth % | 48.75% | 573.74% | 125.99% | - |
| Book Value per Share | 0.06 | 0.04 | 0.01 | -0.02 |
| Total Shareholders' Equity | 1.51M | 1.01M | 150.28K | -578.18K |
| Common Stock | 500 | 500 | 500 | 500 |
| Retained Earnings | 271.79K | -105.23K | -926.85K | -1.12M |
| Treasury Stock | 0 | 0 | 0 | 0 |
| Accumulated OCI | 72.59K | -43.51K | -45.82K | -48.83K |
| Minority Interest | 0 | 0 | 0 | 0 |
Geopolitical and Regulatory Exposure
Based on reported financial figures, the company maintains a cash balance of $547,498, which provides a modest liquidity buffer relative to its scale, though the lack of detailed cash flow data makes it difficult to assess the true sustainability of this reserve against ongoing operational requirements.
The current cash position appears sufficient to cover immediate working capital needs, yet the absence of comprehensive liquidity metrics warrants caution regarding the accessibility of these funds within the Chinese regulatory environment. Investors should monitor whether this cash is being held in a manner that allows for efficient deployment or if it remains trapped by local capital controls.
As indicated by the company's negligible 0.05% debt-to-equity ratio, the firm operates with an exceptionally clean balance sheet that suggests a strategic avoidance of financial leverage, likely to mitigate risks associated with its niche franchise-based distribution model in the People’s Republic of China.
This minimal reliance on external financing implies that the company is not currently exposed to interest rate volatility or refinancing risks. While this conservative capital structure provides a defensive posture, it also suggests that management may be prioritizing balance sheet stability over aggressive expansion or capital-intensive growth initiatives.
According to available financial disclosures, the company's reliance on a franchise-service model introduces significant uncertainty regarding the quality of its intangible assets, as the lack of granular balance sheet data prevents a clear assessment of potential goodwill impairment or the true economic value of its brand.
The discrepancy between the company's high gross margins and its lack of market visibility suggests that the balance sheet may not fully capture the underlying risks of its localized distribution network. Analysts should be wary that the reported figures might mask operational vulnerabilities, particularly if franchise agreements are subject to regulatory shifts or if the brand's intellectual property faces competitive erosion.
Quick answers to the most common questions about buying BYAH stock.
As of 2024, Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) had total assets of $3.1M including $2.8M in current assets.
Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) carries total debt of $0.1M, offset by $0.5M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) has total shareholders' equity (book value) of $1.5M ($0.06 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) reported a current ratio of 1.87x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.